Plenful, a San Francisco, CA-based AI workflow automation platform, raised $17 million in Series A funding, bringing its total raised to more than $25 million.
Investors
The round was led by TQ Ventures, with participation from Bessemer Venture Partners, Mitchell Rales (Co-founder and Chairman of Danaher), Susa Ventures, and existing investors.
Founded in 2018, TQ Ventures is a venture capital investment firm based in New York, New York. The firm focuses on early-stage and growth-stage companies.
Plenful Use of Funds
The company will use the funding to scale across sales, marketing, and product development to continue solving the pharmacy labor shortage.
About Plenful
Founded by Joy Liu, Plenful is a healthcare technology startup that offers AI workflow automation platform designed to streamline and automate a variety of pharmacy administrative tasks. The company serves various types of pharmacies including health system pharmacies, specialty pharmacies, long-term care pharmacies, compounding pharmacies, and specialty providers. Its solutions have been adopted by numerous notable healthcare organizations such as Tampa General Hospital, Renown Health, Salinas Valley Health, and Blue Cross Blue Shield.
Funding Details
Company: Plenful, Inc.
Raised: $17.0M
Round: Series A
Funding Month: May 2024
Lead Investors: TQ Ventures
Additional Investors: Bessemer Venture Partners, Mitchell Rales, Susa Ventures
Company Website: https://www.plenful.com/
Software Category: Healthcare Workflow Automation
Source: https://www.businesswire.com/news/home/20240530190371/en/